Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Regenerative Medicine Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Regenerative Medicine Market Trends and Forecast

The future of the global regenerative medicine market looks promising with opportunities in musculoskeletal disorders, wound care, oncology, ocular disorders, and diabetes. The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030, and it is forecast to grow at a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

  • Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
  • Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
  • North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.

Emerging Trends in the Regenerative Medicine Market

Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.
A total of 94 figures / charts and 87 tables are provided in this more than 184-page report to help in your business decisions. Sample figures with some insights are shown below. 
Regenerative Medicine Market by Material, Product, Application, and Distribution Channel
 

North America will remain the largest region in the Regenerative Medicine Market

  1. United States: Companies like Integra LifeSciences, Organogenesis Holdings Inc., and Acelity are leading innovations in the US market. Initiatives such as the Regenerative Medicine Advanced Therapy (RMAT) designation by the Food and Drug Administration (FDA) accelerate the development and approval of regenerative therapies. The US government invests in regenerative medicine research through agencies like the National Institutes of Health (NIH). 
  2. Germany: German companies like Tissue Regenix Group plc and Osiris Therapeutics GmbH are driving advancements in regenerative medicine. Initiatives such as the German Federal Ministry of Education and Research (BMBF) funding programs support research in tissue engineering and stem cell therapy. The German Medical Association regulates the use of regenerative therapies. 
  3. Japan: Japanese companies like Astellas Pharma Inc. and Fujifilm Cellular Dynamics, Inc. are investing in regenerative medicine technologies. Government initiatives such as the Japan Agency for Medical Research and Development (AMED) fund regenerative medicine research and development. The Pharmaceuticals and Medical Devices Agency (PMDA) regulates regenerative medicine products' safety and efficacy. 
  4. China: Chinese companies like Beike Biotechnology and Shanghai Sunway Biotech Co., Ltd. are expanding their presence in the regenerative medicine market. Government initiatives, including the "Healthy China 2030" plan, promote the development and application of regenerative therapies. The National Medical Products Administration (NMPA) regulates regenerative medicine products. 
  5. United Kingdom: UK companies like ReNeuron Group plc and Cell and Gene Therapy Catapult are at the forefront of regenerative medicine research. Government initiatives such as the Industrial Strategy Challenge Fund support the commercialization of regenerative therapies. The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the regulation of regenerative medicine products. 


In this market, cell-based immunology & cell therapy is the largest product of regenerative medicine, whereas musculoskeletal disorders is the largest application. Growth in various segments of the regenerative medicine market are given below:
Regenerative Medicine Market by Segments
The study includes trends and forecast for the global regenerative medicine market by material, product, application, distribution channel, and region as follows:

By Material [Value ($ Million) shipment analysis for 2018 – 2030]:

  • Synthetic
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Materials
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Materials
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenics
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics

By Product [Value ($ Million) shipment analysis for 2018 – 2030]:

By Application [Value ($ Million) shipment analysis for 2018 – 2030]:

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

By Distribution Channel [Value ($ Million) shipment analysis for 2018 – 2030]:

  • Hospitals
  • Clinics
  • Others

By Region [Value ($ Million) shipment analysis for 2018 – 2030]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

List of Regenerative Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies regenerative medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the regenerative medicine companies profiled in this report include.

Recent Developments in the Regenerative Medicine Market 

  1. FDA Approves First Cell-Based Gene Therapy for Spinal Muscular Atrophy: The U.S. Food and Drug Administration (FDA) approved Novartis' Zolgensma, the first-ever cell-based gene therapy for the treatment of spinal muscular atrophy (SMA). This breakthrough in regenerative medicine offers new hope for patients with this debilitating genetic disorder. 
  2. Organovo Partners with Mayo Clinic for Liver Tissue Engineering Research: Organovo, a leader in 3D bioprinting technology, announced a collaboration with Mayo Clinic to advance liver tissue engineering research. The partnership aims to develop novel regenerative medicine approaches for treating liver diseases and accelerating the development of bioengineered liver tissues for transplantation. 
  3. Stemcell Technologies Launches New Products for Cell Therapy Manufacturing: Stemcell Technologies, a global provider of cell culture media and reagents, launched a suite of new products designed to support cell therapy manufacturing processes. The innovative solutions address key challenges in cell therapy production, facilitating the scalable and efficient manufacturing of regenerative medicine products. 
  4. Takeda Initiates Clinical Trial for Regenerative Therapy in Crohn's Disease: Takeda Pharmaceutical Company Limited initiated a Phase 1/2 clinical trial to evaluate the safety and efficacy of its investigational regenerative therapy in patients with Crohn's disease. The trial aims to assess the potential of regenerative medicine approaches in treating inflammatory bowel diseases.
  5. Orthocell Receives FDA Breakthrough Device Designation for Orthopedic Regenerative Product: Orthocell Limited, an Australian regenerative medicine company, received Breakthrough Device designation from the FDA for its CelGro collagen scaffold product. The designation recognizes the potential of CelGro to address unmet clinical needs in orthopedic surgery and accelerates its pathway to regulatory approval.
Features of the Regenerative Medicine Market
  • Market Size Estimates: Regenerative medicine market size estimation in terms of value ($M).
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Regenerative medicine market size by various segments, such as material, product, application, and distribution channel.
  • Regional Analysis: Regenerative medicine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different material, product, application, distribution channel, and regions for regenerative medicine market.
  • Strategic Analysis: This includes M&A and competitive landscape for the regenerative medicine .
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the regenerative medicine market size?
Answer: The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030.
 Q2. What is the growth forecast for regenerative medicine market?
Answer: The regenerative medicine market is expected to grow at a CAGR of 3.0% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the regenerative medicine market?
Answer: The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.
Q4. What are the major applications or end use industries for regenerative medicine?
Answer: Hospital and clinic are the major end uses for regenerative medicine
Q5. What are the emerging trends in regenerative medicine market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.
Q6. Who are the key regenerative medicine companies?
Answer: Some of the key regenerative medicine companies are as follows:
  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet
Q7.Which regenerative medicine raw material segment will be the largest in future?
Answer: Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
Q8: In regenerative medicine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region in next 5 years.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1 What are some of the most promising potential, high-growth opportunities for the global regenerative medicine market by material (synthetic (scaffold,  artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q. 2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
Q.5 What are the business risks and threats to the market?
Q.6 What are the emerging trends in this market and the reasons behind them?
Q.7 What are some changing demands of customers in the market?
Q.8 What are the new developments in the market? Which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities did take place in the last five years in this market?

For any questions related to regenerative medicine market or related to regenerative medicine companies, regenerative medicine market size, regenerative medicine market share, regenerative medicine analysis, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.

Table of Contents

2. Market Background and Classifications
2.1 Introduction, Background, and Classifications
2.2 Supply Chain
2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1 Macroeconomic Trends and Forecast
3.2 Global Regenerative Medicine Market Trends and Forecast
3.3 Global Regenerative Medicine Market by Material
3.3.1 Synthetic
3.3.1.1 Scaffold
3.3.1.2 Artificial Vascular Graft Materials
3.3.1.3 Hydrogel Materials
3.3.2 Biologically Derived Materials
3.3.2.1 Collagen
3.3.2.2 Xenogeneic Materials
3.3.3 Genetically Engineered Materials
3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
3.3.3.2 Genetically Manipulated Cells
3.3.3.3 Three-dimensional Polymer Technology
3.3.3.4 Transgenics
3.3.3.5 Fibroblasts
3.3.3.6 Neural Stem Cells
3.3.3.7 Gene-activated Matrices
3.3.4 Pharmaceuticals
3.3.4.1 Small Molecules
3.3.4.2 Biologics
3.4 Global Regenerative Medicine Market by Product
3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
3.4.2 Tissue-Engineered Products
3.4.3 Small Molecules And Biologics
3.4.4 Gene Therapy Products
3.5 Global Regenerative Medicine Market by Application
3.5.1 Musculoskeletal Disorders
3.5.2 Wound Care
3.5.3 Oncology
3.5.4 Ocular Disorders
3.5.5 Diabetes
3.5.6 Other Applications
3.6 Global Regenerative Medicine Market by Distribution Channel
3.6.1 Hospitals
3.6.2 Clinic
3.6.3 Others

4. Market Trends and Forecast Analysis by Region
4.1 Global Regenerative Medicine Market by Region
4.2 North American Regenerative Medicine Market
4.2.1 Market by Material: Synthetic (Scaffold,  Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.2.5 The United States Regenerative Medicine Market
4.2.6 The Canadian Regenerative Medicine Market
4.2.7 The Mexican Regenerative Medicine Market
4.3 European Regenerative Medicine Market
4.3.1 Market by Material: Synthetic (Scaffold,  Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.3.5 The Regenerative Medicine Market of the United Kingdom
4.3.6 The German Regenerative Medicine Market
4.3.7 The French Regenerative Medicine Market
4.4  APAC Regenerative Medicine Market
4.4.1 Market by Material: Synthetic (Scaffold,  Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.4.5 The Chinese Regenerative Medicine Market
4.4.6 The Indian Regenerative Medicine Market
4.4.7 The Japanese Regenerative Medicine Market
4.5 ROW Regenerative Medicine Market
4.5.1 Market by Material: Synthetic (Scaffold,  Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis
5.1 Market Share Analysis
5.2 Product Portfolio Analysis
5.3 Operational Integration
5.4 Geographical Reach
5.5 Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1 Growth Opportunity Analysis
6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
6.2 Emerging Trends in the Global Regenerative Medicine Market
6.3 Strategic Analysis
6.3.1 New Product Development
6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine  Market

7. Company Profiles of Leading Players
7.1 Kite Pharma
7.2 Novartis
7.3 Vericel Corporation
7.4 Integra LifeSciences
7.5 Wright Medical
7.6 MiMedx
7.7 Osiris Therapeutics
7.8 Stryker Corporation
7.9 Spark Therapeutics
7.10 Zimmer Biomet Holdings, Inc.

.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Regenerative Medicine Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
94 figures/charts and 87 tables are provided in this 184- page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.